Updates of CSCO guidelines for colorectal cancer version 2025

Demin Lu, Caixia Dong, Kailai Wang, Chenyang Ye, Liubo Chen, Ying Yuan, Hanguang Hu

2025, 37(3): 297-302. doi: 10.21147/j.issn.1000-9604.2025.03.01

Deep learning-based differentiation of benign and malignant thyroid follicular neoplasms on multiscale intraoperative frozen pathological images: A multicenter diagnostic study

Jiahui Liu, Chuanguang Xiao, Haicheng Zhang, Pengyi Yu, Qi Wang, Ziru Peng, Guohua Yu, Ping Yang, Yakui Mou, Chuanliang Jia, Hongxia Cheng, Ning Mao, Xicheng Song

2025, 37(3): 303-315. doi: 10.21147/j.issn.1000-9604.2025.03.02

Multi-omics profile of exceptional long-term survivors of AJCC stage III triple-negative breast cancer

Yang Ou-Yang, Caijin Lin, Yifan Xie, Xiaoqing Song, Yi-Zhou Jiang

2025, 37(3): 316-336. doi: 10.21147/j.issn.1000-9604.2025.03.03

Comparison of efficacy and safety of a proposed biosimilar QL1206 with reference denosumab in patients with bone metastasis from breast cancer: A subgroup analysis of a randomized, double-blinded phase III study

Yaxin Liu, Ruyan Zhang, Xiaojia Wang, Lijun Di, Zhendong Chen, Jingfen Wang, Tao Sun, Qingshan Li, Jing Cheng, Qingyuan Zhang, Xiuwen Wang, Junye Wang, Kangsheng Gu, Shihong Wei, Shuqun Zhang, Xiangcai Wang, Ping Sun, Chunfang Hao, Aimin Zang, Yujie Li, Cuicui Han, Xiaoyan Kang, Yanling Li, Huiping Li

2025, 37(3): 337-351. doi: 10.21147/j.issn.1000-9604.2025.03.04

Evaluation of two algorithms measuring homologous recombination deficiency status in prognostic assessment for treatment-naïve non-small cell lung cancer

Yidan Ma, Jingyu Huang, Lei He, Jun Du, Longteng Liu, Xiaoguang Li, Peng Jiao, Xiaonan Wu, Wei Zhou, Xiaomao Xu, Li Yang, Jing Di, Changbin Zhu, Lin Li, Dongge Liu, Zheng Wang

2025, 37(3): 352-364. doi: 10.21147/j.issn.1000-9604.2025.03.05

Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: An individual patient data meta-analysis of KLASS-02 and CLASS-01 randomized controlled trials

Yanfeng Hu, Woo Jin Hyung, Huilin Huang, Changming Huang, Han-Kwang Yang, Yihong Sun, Young-Kyu Park, Xiangqian Su, Hyuk-Joon Lee, Hui Cao, Ji Yeong An, Jiankun Hu, Wook Kim, Kuan Wang, Hyoung-Il Kim, Jian Suo, Hyung-Ho Kim, Kaixiong Tao, Seung Wan Ryu, Xianli He, Hoon Hur, Hongbo Wei, Min-Chan Kim, Seong-Ho Kong, Mingang Ying, Gyu Seok Cho, Weiguo Hu, Jin-Jo Kim, Xiaohui Du, Do Joong Park, Jiang Yu, Keun Won Ryu, Hao Liu, Young Woo Kim, Ziyu Li, Jong Won Kim, Jiafu Ji, Joo-Ho Lee, Guoxin Li, Sang-Uk Han

2025, 37(3): 365-376. doi: 10.21147/j.issn.1000-9604.2025.03.06

Development and validation of machine learning-based survival analysis to predict outcome in gastric cancer with adjuvant chemotherapy: A multicenter, longitudinal, cohort study

Yan Pan, Linbin Lu, Xianchun Gao, Jun Yu, Sitian Dai, Ruirong Yao, Ning Han, Xinlin Wang, Abudurousuli Reyila, Shibo Wang, Junya Yan, Zhen Xu, Yuanyuan Lu, Mengbin Li, Jipeng Li, Jiayun Liu, Qingchuan Zhao, Kaichun Wu, Yongzhan Nie

2025, 37(3): 377-389. doi: 10.21147/j.issn.1000-9604.2025.03.07

Potential impact of controlling risk factors on future liver cancer deaths in China

Mengdi Cao, Yi Teng, Qianru Li, Nuopei Tan, Jiachen Wang, Tingting Zuo, Tianyi Li, Yuanjie Zheng, Changfa Xia, Wanqing Chen

2025, 37(3): 390-403. doi: 10.21147/j.issn.1000-9604.2025.03.08

Discovery and validation of indole nitroolefins as novel covalent GPX4 inhibitors for inducing ferroptosis in urological cancers

Na Zeng, Guichen Ye, Mengchu Zheng, Guangyuan Liu, Sihan Zhang, Siyang Ma, Zhiyu Xia, Yirong Zhou, Shaogang Wang, Qidong Xia

2025, 37(3): 404-416. doi: 10.21147/j.issn.1000-9604.2025.03.09

Venetoclax and azacitidine compared with intensive chemotherapy for adverse-risk acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation in first complete remission: A multicenter study of TROPHY group

Qi Wen, Chuanhe Jiang, Xiaodan Liu, Yi Xia, Yilei Ma, Yang Yang, Yu Wang, Yingjun Chang, Luxiang Wang, Zilu Zhang, Xiaojun Huang, Yang Cao, Yanmin Zhao, Xiaoxia Hu, Xiaodong Mo

2025, 37(3): 417-431. doi: 10.21147/j.issn.1000-9604.2025.03.10

Immune cell metabolism in cancer drug resistance: Advances in target discovery and clinical translation

Liangjie Sun, Guo Zhao, Shuhang Wang, Ning Li

2025, 37(3): 432-445. doi: 10.21147/j.issn.1000-9604.2025.03.11

Tumor-educated cells in tumor microenvironment: Key drivers of immunotherapy resistance

Ji’an Zou, Shuxing Wang, Yingzhe Zhang, Wentao Tian, Ge Mai, Yiting Xu, Wenjie Xiao, Edward E. Graves, Fang Wu

2025, 37(3): 446-465. doi: 10.21147/j.issn.1000-9604.2025.03.12

Molecular insights into immune evasion and therapeutic paradigms in pancreatic cancer

Ming Li, Renyu Zhou, Yu Qiu, Yulong Peng, Minting Liu, Xiaotan Zhang

2025, 37(3): 466-486. doi: 10.21147/j.issn.1000-9604.2025.03.13